Cargando…

Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy

DNA double-strand break (DSB) is considered the most deleterious type of DNA damage, which is generated by ionizing radiation (IR) and a subset of anticancer drugs. DNA-dependent protein kinase (DNA-PK), which is composed of a DNA-PK catalytic subunit (DNA-PKcs) and Ku80-Ku70 heterodimer, acts as th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Matsumoto, Yoshihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032228/ https://www.ncbi.nlm.nih.gov/pubmed/35457081 http://dx.doi.org/10.3390/ijms23084264

Ejemplares similares

DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated
por: Matsumoto, Yoshihisa, et al.
Publicado: (2021)

Differential expression of DNA-dependent protein kinase catalytic subunit in the brain of neonatal mice and young adult mice
por: OKAWA, Aoi, et al.
Publicado: (2020)

Identification of DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs) as a Novel Target of Bisphenol A
por: Ito, Yuki, et al.
Publicado: (2012)

Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
por: Kumar, Sandeep, et al.
Publicado: (2020)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Autophosphorylation and Self-Activation of DNA-Dependent Protein Kinase
por: Kurosawa, Aya
Publicado: (2021)

DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease
por: Kanungo, Jyotshna
Publicado: (2013)

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
por: Gjertsen, B T, et al.
Publicado: (2015)

cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
por: Wolfertstetter, Stefanie, et al.
Publicado: (2013)

DNA–dependent protein kinase in telomere maintenance and protection
por: Sui, Jiangdong, et al.
Publicado: (2020)

Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy
por: Mohammad, Taj, et al.
Publicado: (2019)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer
por: Someya, M, et al.
Publicado: (2011)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
por: Ullah, Zakir, et al.
Publicado: (2009)

Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network
por: D’Incal, Claudio, et al.
Publicado: (2022)

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective
por: Sonawane, Yogesh A., et al.
Publicado: (2016)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
por: Pan, Xiaoli, et al.
Publicado: (2022)

Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
por: Jampilek, Josef, et al.
Publicado: (2022)

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
por: Li, Bin-Bin, et al.
Publicado: (2019)

Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer
por: Grela-Wojewoda, Aleksandra, et al.
Publicado: (2022)

Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer
por: Viganò, Mauro, et al.
Publicado: (2023)

The role of DNA dependent protein kinase in synapsis of DNA ends
por: Weterings, Eric, et al.
Publicado: (2010)

Activation Mechanism of Protein Kinase B by DNA-dependent Protein Kinase Involved in the DNA Repair System
por: Li, Yuwen, et al.
Publicado: (2008)

Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity
por: Hosoi, Y, et al.
Publicado: (2002)

Evolution of Bacterial Protein-Tyrosine Kinases and Their Relaxed Specificity Toward Substrates
por: Shi, Lei, et al.
Publicado: (2014)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
por: Zhao, Wennan, et al.
Publicado: (2017)

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
por: Pottier, Charles, et al.
Publicado: (2020)

Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective
por: Russo, Eleonora, et al.
Publicado: (2021)

DNA-dependent protein kinase in nonhomologous end joining: a lock with multiple keys?
por: Weterings, Eric, et al.
Publicado: (2007)

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
por: Juric, Viktorija, et al.
Publicado: (2020)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
por: Łukasik, Paweł, et al.
Publicado: (2021)

The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
por: Nitulescu, George Mihai, et al.
Publicado: (2023)

Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
por: Zhao, Melody, et al.
Publicado: (2023)

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
por: Brana, Irene, et al.
Publicado: (2012)

Protein kinase inhibitors for acute leukemia
por: Ling, Yuan, et al.
Publicado: (2018)

Targeting Protein Kinase C for Cancer Therapy
por: He, Sijia, et al.
Publicado: (2022)

Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders
por: Kawauchi, Takeshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kf8o0dphaafifd3ki6gpavb4fu